-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明，无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
Cerus (NASDAQ:CERS) Reaches New 52-Week Low at $3.42
Cerus (NASDAQ:CERS) Reaches New 52-Week Low at $3.42
Cerus Co. (NASDAQ:CERS – Get Rating) shares hit a new 52-week low during trading on Tuesday . The company traded as low as $3.42 and last traded at $3.42, with a volume of 30076 shares. The stock had previously closed at $3.47.
Cerus Trading Down 1.7 %
The stock has a market cap of $603.88 million, a P/E ratio of -14.46 and a beta of 1.14. The company has a debt-to-equity ratio of 0.53, a current ratio of 2.08 and a quick ratio of 1.73. The business's 50 day simple moving average is $4.68 and its 200 day simple moving average is $4.98.
Get Cerus alerts:Insider Activity
In other news, insider Richard J. Benjamin sold 10,000 shares of Cerus stock in a transaction that occurred on Tuesday, August 9th. The shares were sold at an average price of $5.12, for a total value of $51,200.00. Following the completion of the transaction, the insider now owns 172,665 shares in the company, valued at $884,044.80. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 7.33% of the stock is currently owned by corporate insiders.
Institutional Inflows and Outflows
A number of institutional investors have recently modified their holdings of the company. Legal & General Group Plc raised its stake in shares of Cerus by 9.9% in the second quarter. Legal & General Group Plc now owns 328,358 shares of the biotechnology company's stock valued at $1,737,000 after acquiring an additional 29,597 shares during the last quarter. ExodusPoint Capital Management LP raised its position in Cerus by 3.8% in the 2nd quarter. ExodusPoint Capital Management LP now owns 233,339 shares of the biotechnology company's stock worth $1,234,000 after purchasing an additional 8,516 shares during the last quarter. Walleye Capital LLC bought a new position in Cerus in the 2nd quarter worth approximately $154,000. Goldman Sachs Group Inc. raised its position in Cerus by 102.4% in the 2nd quarter. Goldman Sachs Group Inc. now owns 863,845 shares of the biotechnology company's stock worth $4,570,000 after purchasing an additional 437,101 shares during the last quarter. Finally, Tamarack Advisers LP raised its position in Cerus by 21.2% in the 2nd quarter. Tamarack Advisers LP now owns 2,000,000 shares of the biotechnology company's stock worth $10,580,000 after purchasing an additional 350,000 shares during the last quarter. Institutional investors own 84.72% of the company's stock.About Cerus
(Get Rating)
Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended for transfusion.
Further Reading
- Get a free copy of the StockNews.com research report on Cerus (CERS)
- Build A Better Tech Portfolio With Jabil Inc.
- Is There Value In These Growth Stocks?
- Autodesk Is A Mature Company Still Acting Like A Growth Stock
- MarketBeat Podcast, 3 Stocks to Watch Newmont Mining, Walmart, AMC
- Is the Market Overreacting with Shopify Stock?
Receive News & Ratings for Cerus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cerus and related companies with MarketBeat.com's FREE daily email newsletter.
Cerus Co. (NASDAQ:CERS – Get Rating) shares hit a new 52-week low during trading on Tuesday . The company traded as low as $3.42 and last traded at $3.42, with a volume of 30076 shares. The stock had previously closed at $3.47.
赛乐斯公司(纳斯达克代码：CERS-GET Rating)的股价周二创下52周新低。该公司股价最低跌至3.42美元，最新报3.42美元，成交量为30076股。该股此前收盘价为3.47美元。
Cerus Trading Down 1.7 %
Cerus交易下跌1.7%
The stock has a market cap of $603.88 million, a P/E ratio of -14.46 and a beta of 1.14. The company has a debt-to-equity ratio of 0.53, a current ratio of 2.08 and a quick ratio of 1.73. The business's 50 day simple moving average is $4.68 and its 200 day simple moving average is $4.98.
该股市值为6.0388亿美元，市盈率为-14.46，贝塔系数为1.14。该公司的债务权益比为0.53，流动比率为2.08，速动比率为1.73。该业务的50日简单移动均线切入位为4.68美元，200日简单移动均线切入位为4.98美元。
Insider Activity
内幕活动
In other news, insider Richard J. Benjamin sold 10,000 shares of Cerus stock in a transaction that occurred on Tuesday, August 9th. The shares were sold at an average price of $5.12, for a total value of $51,200.00. Following the completion of the transaction, the insider now owns 172,665 shares in the company, valued at $884,044.80. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 7.33% of the stock is currently owned by corporate insiders.
在其他新闻方面，内部人士理查德·J·本杰明在8月9日星期二的一笔交易中出售了10,000股Cerus股票。这些股票的平均价格为5.12美元，总价值为51,200.00美元。交易完成后，这位内部人士现在拥有该公司172,665股股票，价值884,044.80美元。这笔交易是在提交给美国证券交易委员会的一份文件中披露的，该文件可通过此超链接。7.33%的股份目前由企业内部人士持有。
Institutional Inflows and Outflows
机构资金流入和流出
About Cerus
关于Cerus
(Get Rating)
(获取评级)
Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended for transfusion.
Cerus公司是一家生物医药产品公司。该公司专注于开发拦截血液系统并将其商业化，以增强血液安全。其拦截血液系统，这是一项控制生物复制的专利技术，旨在减少用于输血的捐献血液成分中的血源性病原体。
Further Reading
进一步阅读
- Get a free copy of the StockNews.com research report on Cerus (CERS)
- Build A Better Tech Portfolio With Jabil Inc.
- Is There Value In These Growth Stocks?
- Autodesk Is A Mature Company Still Acting Like A Growth Stock
- MarketBeat Podcast, 3 Stocks to Watch Newmont Mining, Walmart, AMC
- Is the Market Overreacting with Shopify Stock?
- 免费获取StockNews.com关于Cerus的研究报告(CERS)
- 与捷普公司一起打造更好的技术产品组合。
- 这些成长型股票有价值吗？
- 欧特克是一家成熟的公司，仍是一只成长型股票
- MarketBeat Podcast，3只股票关注纽蒙特矿业、沃尔玛、AMC
- 市场是否对Shopify Stock反应过度？
Receive News & Ratings for Cerus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cerus and related companies with MarketBeat.com's FREE daily email newsletter.
接受《Cerus Daily》的新闻和评级-在下面输入您的电子邮件地址，通过MarketBeat.com的免费每日电子邮件时事通讯接收对Cerus和相关公司的最新新闻和分析师评级的每日简要摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国，moomoo上的投资产品和服务由Moomoo Financial Inc.提供，一家受美国证券交易委员会（SEC）监管的持牌主体。 Moomoo Financial Inc.是金融业监管局（FINRA）和证券投资者保护公司（SIPC）的成员。
在新加坡，moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供，该公司受新加坡金融管理局（MAS）监管(牌照号码︰CMS101000) ，持有资本市场服务牌照 (CMS) ，持有财务顾问豁免（Exempt Financial Adviser）资质。本内容未经新加坡金融管理局的审查。
在澳大利亚，moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供，该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构（AFSL No. 224663）。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件，这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大，通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供，并受加拿大投资监管机构（CIRO）监管。
在马来西亚，moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供，该公司受马来西亚证券监督委员会（SC）监管(牌照号码︰eCMSL/A0397/2024) ，持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
风险及免责提示
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国，moomoo上的投资产品和服务由Moomoo Financial Inc.提供，一家受美国证券交易委员会（SEC）监管的持牌主体。 Moomoo Financial Inc.是金融业监管局（FINRA）和证券投资者保护公司（SIPC）的成员。
在新加坡，moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供，该公司受新加坡金融管理局（MAS）监管(牌照号码︰CMS101000) ，持有资本市场服务牌照 (CMS) ，持有财务顾问豁免（Exempt Financial Adviser）资质。本内容未经新加坡金融管理局的审查。
在澳大利亚，moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供，该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构（AFSL No. 224663）。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件，这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大，通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供，并受加拿大投资监管机构（CIRO）监管。
在马来西亚，moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供，该公司受马来西亚证券监督委员会（SC）监管(牌照号码︰eCMSL/A0397/2024) ，持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能，分享给你的好友吧